MENU
ERAS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Erasca (ERAS) Earnings Date & Reports

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

A.I. Advisor
published Earnings

ERAS is expected to report earnings to rise 16.91% to -12 cents per share on May 08

Erasca ERAS Stock Earnings Reports
Q1'25
Est.
$-0.13
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.11
Q1'24
Missed
by $0.03
The last earnings report on March 20 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 1.12M shares outstanding, the current market capitalization sits at 341.34M.
View a ticker or compare two or three
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3115 Merryfield Row
Phone
+1 858 465-6511
Employees
126
Web
https://www.erasca.com